AKT1 and B-cell chronic lymphocytic leukemia: The reduced sensitivity of TP53ko CLL cells to ONC‐212 (Figure 1B) may be related to the increased phosphorylation of AKT we observed in the TP53ko cells following ONC‐212 treatment (Figure S2B).